Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

12
results for

"Focal nodular hyperplasia"

Article category

Keywords

Publication year

"Focal nodular hyperplasia"

Review

Benign liver tumors and cystic disease of liver

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma
Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso
Clin Mol Hepatol 2016;22(2):199-211.
Published online May 18, 2016
DOI: https://doi.org/10.3350/cmh.2016.0101
Owing to the progress of imaging techniques, benign hepatocellular nodules are increasingly discovered in the clinical practice. This group of lesions mostly arises in the context of a putatively normal healthy liver and includes either pseudotumoral and tumoral nodules. Focal nodular hyperplasia and hepatocellular adenoma are prototypical examples of these two categories of nodules. In this review we aim to report the main pathological criteria of differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma, which mainly rests upon morphological and phenotypical features. We also emphasize that for a correct diagnosis the clinical context such as sex, age, assumption of oral contraceptives, associated metabolic or vascular disturbances is of paramount importance. While focal nodular hyperplasia is a single entity epidemiologically more frequent than adenoma, the latter is representative of a more heterogeneous group which has been recently and extensively characterized from a clinical, morphological, phenotypical and molecular profile. The use of the liver biopsy in addition to imaging and the clinical context are important diagnostic tools of these lesions. In this review we will survey their systematic pathobiology and propose a diagnostic algorithm helpful to increase the diagnostic accuracy of not dedicated liver pathologists. The differential diagnosis between so-called typical and atypical adenoma and well differentiated hepatocellular carcinoma will also be discussed.

Citations

Citations to this article as recorded by  Crossref logo
  • PET/MRI evaluation of hepatobiliary tumors
    Joseph FRANKL, Naveen RAJAMOHAN, Jaewon YANG, Robert C. SIBLEY
    The Quarterly Journal of Nuclear Medicine and Molecular Imaging.2025;[Epub]     CrossRef
  • Diagnosis and Management of Benign Liver Tumors
    Yeonjung Ha
    The Korean Journal of Gastroenterology.2025; 85(3): 314.     CrossRef
  • Hepatocellular adenomas
    Hans-Christian Pommergaard, Henning Grønbæk, Eva Fallentin, Nikolaj Skou, Nicolai Aagaard Schultz, Mette Bak Nielsen, Gro Linno Willemoe
    Ugeskrift for Læger.2025; : 1.     CrossRef
  • Focal Hyperechoic Hepatic Lesions in Northern Region of Saudi Arabia: Prevalence, Radiologic Features, and Clinical Relevance
    Fatimah M. Alonzi, Mohammed J. Alsaadi, Khaled Said Karam, Essa M. Alanzi, Noura K. Alhathal, Maram F. Alreshidi, Abdulrahman M. Alfuraih
    Journal of Clinical Medicine.2025; 14(19): 6987.     CrossRef
  • Focal nodular hyperplasia combined with hepatocellular carcinoma with bone metastasis: a case report and literature review
    Yuliang Zhang, Xiyue Deng, Kaiyue Cao, Yang Li
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Variation in the management of benign liver tumors: A European survey and case vignette study
    Martijn P.D. Haring, Robbert J. de Haas, Frederike G.I. van Vilsteren, Joost M. Klaase, Evelien W. Duiker, Hans Blokzijl, Koert P. de Jong, Vincent E. de Meijer, Frans J.C. Cuperus, Y.S. de Boer, R.A. de Man, C.M. den Hoed, J.P.H. Drenth, M.G. Garcovich,
    Clinics and Research in Hepatology and Gastroenterology.2023; 47(3): 102094.     CrossRef
  • Hepatocellular Neoplasm of Uncertain Potential of Malignancy or Well-Differentiated Hepatocellular Carcinoma Arising within Hepatocellular Adenoma
    Elisabete Campos, Roberto Silva, Sara Rodrigues, Marinho de Almeida, Joanne Lopes, Marisa Aral, Humberto Cristino, Luís Graça, Elisabete Barbosa, Neil Donald Merrett
    Case Reports in Surgery.2023; 2023: 1.     CrossRef
  • Desmoplastic small round cell tumor of the liver: diagnosing a rare case on liver biopsy
    Xiao Feng, Jing Tao, Qiang Zhou, Yi-Dan Qiao, Le-Jian He, Nan Zhang
    Diagnostic Pathology.2023;[Epub]     CrossRef
  • Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out?
    Christos Tsalikidis, Athanasia Mitsala, George Pappas-Gogos, Konstantinos Romanidis, Alexandra K. Tsaroucha, Michail Pitiakoudis
    Journal of Clinical Medicine.2023; 12(18): 6034.     CrossRef
  • Significance of hepatocyte atypia in liver fine needle aspiration
    Susan Shyu, Syed Z. Ali
    Diagnostic Cytopathology.2022; 50(4): 186.     CrossRef
  • Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results
    Helmut Denk, Daniela Pabst, Peter M. Abuja, Robert Reihs, Brigitte Tessaro, Kurt Zatloukal, Carolin Lackner
    Modern Pathology.2022; 35(1): 87.     CrossRef
  • Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice
    Elvire Desjonqueres, Claudia Campani, Fabio Marra, Jessica Zucman‐Rossi, Jean‐Charles Nault
    Liver International.2022; 42(3): 492.     CrossRef
  • Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report
    Caner Ercan, Mairene Coto-Llerena, John Gallon, Lana Fourie, Mattia Marinucci, Gabriel F. Hess, Jürg Vosbeck, Stephanie Taha-Mehlitz, Tuyana Boldanova, Marie-Anne Meier, Alexandar Tzankov, Matthias S. Matter, Martin H. K. Hoffmann, Luca Di Tommaso, Markus
    Communications Medicine.2022;[Epub]     CrossRef
  • Comparison of the Value of Color Doppler Ultrasound and Multislice Spiral CT in the Differential Diagnosis of Benign and Malignant Nodules in the Liver
    Peiwan Jia, Ruirong Liu, Yun Liu, Yanyan Wu, Ting Dou, Yuvaraja Teekaraman
    Contrast Media & Molecular Imaging.2022;[Epub]     CrossRef
  • Magnetic Resonance Imaging Findings of an Intrahepatic Bile Duct Adenoma: A Case Report
    Jie Yuan, Kun Liu, Mengxiao Liu, Songhua Zhan
    Cureus.2022;[Epub]     CrossRef
  • Liver Abnormalities in Turner Syndrome: The Importance of Estrogen Replacement
    Istvan Fedor, Eva Zold, Zsolt Barta
    Journal of the Endocrine Society.2022;[Epub]     CrossRef
  • Microvascular imaging: new Doppler technology for assessing focal liver lesions. Is it useful?
    A. Wilson, A.K.P. Lim
    Clinical Radiology.2022; 77(12): e807.     CrossRef
  • A focalis nodularis hyperplasia multimodális kezelése
    Damján Pekli, Bálint Kokas, Dávid Bárdos, András Fülöp, Péter Pajor, Oszkár Hahn, Ildikó Illyés, Attila Kovács, Attila Szijártó
    Orvosi Hetilap.2022; 163(15): 606.     CrossRef
  • CT-Based Radiomics Nomogram: A Potential Tool for Differentiating Hepatocellular Adenoma From Hepatocellular Carcinoma in the Noncirrhotic Liver
    Pei Nie, Ning Wang, Jing Pang, Guangjie Yang, Shaofeng Duan, Jingjing Chen, Wenjian Xu
    Academic Radiology.2021; 28(6): 799.     CrossRef
  • Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors
    Olga Y. Burenina, Natalia L. Lazarevich, Inna F. Kustova, Daria A. Shavochkina, Ekaterina A. Moroz, Nikolay E. Kudashkin, Yuriy I. Patyutko, Alexey V. Metelin, Eduard F. Kim, Dmitry A. Skvortsov, Timofei S. Zatsepin, Maria P. Rubtsova, Olga A. Dontsova
    Journal of Cancer Research and Clinical Oncology.2021; 147(1): 49.     CrossRef
  • Benign hepatocellular lesions and neoplasms: a comprehensive review
    Luiz Paulo Guido, Monica T. Garcia-Buitrago
    Diagnostic Histopathology.2021; 27(2): 85.     CrossRef
  • Hepatocellular adenomas: recent updates
    Haeryoung Kim, Young Nyun Park
    Journal of Pathology and Translational Medicine.2021; 55(3): 171.     CrossRef
  • Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma
    L. A. de Wert, S. A. Huisman, F. Imani, D. J. de Gooyer, J. M. G. H. van Riel, P. D. Gobardhan, A. M. Rijken, Mario Ganau
    Case Reports in Surgery.2021; 2021: 1.     CrossRef
  • Scoping review of clinical practice guidelines on the management of benign liver tumours
    Martijn P D Haring, Frans J C Cuperus, Evelien W Duiker, Robbert J de Haas, Vincent E de Meijer
    BMJ Open Gastroenterology.2021; 8(1): e000592.     CrossRef
  • Diagnosis and surgical treatment of a rare hepatic angiomyolipoma with internal hemorrhage
    Mizelle D'Silva, Hee Young Na, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim
    Annals of Hepato-Biliary-Pancreatic Surgery.2021; 25(4): 532.     CrossRef
  • Alpha‐fetoprotein and focal nodular hyperplasia: An unconventional couple
    Paul Carrier, Anne Guyot, Marilyne Debette‐Gratien, Fabien Fredon, Marie‐Pierre Teissier, François Labrousse, Véronique Loustaud‐Ratti
    JGH Open.2021; 5(11): 1316.     CrossRef
  • Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome
    Morgane Van Wettere, Luisa Paulatto, Lucas Raynaud, Onorina Bruno, Audrey Payancé, Aurélie Plessier, Pierre-Emmanuel Rautou, Valérie Paradis, Dominique Cazals-Hatem, Dominique Valla, Valérie Vilgrain, Maxime Ronot
    JHEP Reports.2020; 2(3): 100097.     CrossRef
  • Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI
    Cathryn L Hui, Marcela Mautone
    The British Journal of Radiology.2020;[Epub]     CrossRef
  • Focal Nodular Hyperplasia and Hepatic Adenoma
    Lauren Myers, Joseph Ahn
    Clinics in Liver Disease.2020; 24(3): 389.     CrossRef
  • OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd‐EOB‐DTPA uptake and correlates with risk of malignancy
    Amedeo Sciarra, Sabine Schmidt, Alessandro Pellegrinelli, Marco Maggioni, Daniele Dondossola, Jerome Pasquier, Claudia Cigala, Delfina Tosi, Nermin Halkic, Gaetano Bulfamante, Giuseppe Viale, Silvano Bosari, Charles Balabaud, Paulette Bioulac‐Sage, Christ
    Liver International.2019; 39(1): 158.     CrossRef
  • MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma
    Gábor Lendvai, Tímea Szekerczés, Benedek Gyöngyösi, Krisztina Schlachter, Endre Kontsek, Adrián Pesti, Attila Patonai, Klára Werling, Ilona Kovalszky, Zsuzsa Schaff, András Kiss
    Pathology & Oncology Research.2019; 25(3): 1103.     CrossRef
  • Challenging liver lesions in noncirrhotic patients: Report of three cases
    Tania Franceschini, Deborah Malvi, Lorenzo Maroni, Matteo Ravaioli, Matteo Cescon, Antonia D’Errico, Francesco Vasuri
    Therapeutic Advances in Gastrointestinal Endoscopy.2019;[Epub]     CrossRef
  • Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection
    Ying Yan, Lena Allweiss, Danli Yang, Jingting Kang, Jianwen Wang, Xiangjun Qian, Ting Zhang, Hui Liu, Lu Wang, Shuhong Liu, Jianhua Sui, Xiangmei Chen, Maura Dandri, Jingmin Zhao, Fengmin Lu
    Emerging Microbes & Infections.2019; 8(1): 879.     CrossRef
  • Multi-parameter ultrasound based on the logistic regression model in the differential diagnosis of hepatocellular adenoma and focal nodular hyperplasia
    Meng Wu, Ru-Hai Zhou, Feng Xu, Xian-Peng Li, Ping Zhao, Rui Yuan, Yu-Peng Lan, Wei-Xia Zhou
    World Journal of Gastrointestinal Oncology.2019; 11(12): 1193.     CrossRef
  • Focal Nodular Hyperplasia in a Young Male as an Incidental Finding Associated With Acute Lithiasic Chronic Cholecystitis. Case Report and Literature Review
    José J. Gómez-Ramos, María G. Ascencio-Rodríguez, Alejandro Marín-Medina, Moises Alejandro Alatorre Jimenez, Vickramjeet Johal, Eduardo Esteban-Zubero
    Iberoamerican Journal of Medicine.2019; 1(1): 16.     CrossRef
  • Primary Liver Cancers—Part 1
    Kun Jiang, Sameer Al-Diffalha, Barbara A. Centeno
    Cancer Control.2018;[Epub]     CrossRef
  • Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing
    Jian Zheng, Eran Sadot, Joana A. Vigidal, David S. Klimstra, Vinod P. Balachandran, T. Peter Kingham, Peter J. Allen, Michael I. D’Angelica, Ronald P. DeMatteo, William R. Jarnagin, Andrea Ventura, Yu-Jia Chang
    PLOS ONE.2018; 13(7): e0200776.     CrossRef
  • Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma
    Archana Rastogi
    World Journal of Gastroenterology.2018; 24(35): 4000.     CrossRef
  • A practical diagnostic approach to hepatic masses
    Monika Vyas, Dhanpat Jain
    Indian Journal of Pathology and Microbiology.2018; 61(1): 2.     CrossRef
  • Hepatocellular adenoma: Classification, variants and clinical relevance
    Paulette Bioulac-Sage, Christine Sempoux, Charles Balabaud
    Seminars in Diagnostic Pathology.2017; 34(2): 112.     CrossRef
  • Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How
    Luca Di Tommaso, Massimo Roncalli
    Frontiers in Medicine.2017;[Epub]     CrossRef
  • Comparison of Subtypes of Hepatocellular Adenoma to Hepatocellular Carcinoma and Non-Neoplastic Liver Tissue in Terms of PTEN Expression
    Grzegorz Szparecki, T. Ilczuk, N. Gabzdyl, B. Górnicka
    Folia Biologica.2017; 63(5-6): 202.     CrossRef
  • Leberadenome und andere maligne und benigne Lebertumoren
    F. Hartmann, A. Tannapfel
    Der Gastroenterologe.2016; 11(5): 359.     CrossRef
  • 24,732 View
  • 639 Download
  • 44 Web of Science
  • Crossref

Case Report

Benign liver tumors and cystic disease of liver

A case of focal nodular hyperplasia with growth progression during pregnancy
Min Ji Kim, Sang Young Han, Yang Hyun Baek, Sung Wook Lee, Hee Jin Kwon
Clin Mol Hepatol 2014;20(4):392-397.
Published online December 24, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.4.392

Focal nodular hyperplasia (FNH) is the second most common benign solid tumor of the liver and is usually found in young females. In FNH, spontaneous bleeding or rupture rarely occurs and malignant transformation is unlikely. The etiology of FNH is unclear, but because of female predominance and young age at onset, it seems that female hormone has an important role for the development of FNH. Although the development and the complications of hepatocellular adenomas have been related to the use of oral contraceptives and pregnancy, the influence of oral contraceptives and pregnancy on the growth and complications of FNH is controversial. Most FNH are stable in size and rarely complicated during pregnancy. We describe here a case of FNH with growth progression during pregnancy in a 27-year-old female. Her course of pregnancy and delivery was uneventful. Two months after delivery, the size of FNH was decreased.

Citations

Citations to this article as recorded by  Crossref logo
  • Arterial embolization of focal nodular hyperplasia of the liver: A case report
    Hiba Ben Hassine, Mohamed Ali Chaouch, Maissa Jallali, Hanen Zenati, Besma Gafsi, Faouzi Noomen
    International Journal of Surgery Case Reports.2024; 116: 109473.     CrossRef
  • Imaging strategy for focal nodular hyperplasia in children: long-term experience from two specialist European centres
    Greg Chambers, Angelo Zarfati, Tobi Aderotimi, Sophie Branchereau, Terry Humphrey, Helen Woodley, Stéphanie Franchi-Abella
    Pediatric Radiology.2023; 53(1): 46.     CrossRef
  • Large focal nodular hyperplasia of the liver treated with transcatheter arterial embolization and laparoscopic resection: A case report
    Hiroki Sato, Kazuteru Monden, Toshimitsu Iwasaki, Masayoshi Hioki, Hiroshi Sadamori, Norihisa Takakura
    Asian Journal of Endoscopic Surgery.2023; 16(3): 579.     CrossRef
  • Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out?
    Christos Tsalikidis, Athanasia Mitsala, George Pappas-Gogos, Konstantinos Romanidis, Alexandra K. Tsaroucha, Michail Pitiakoudis
    Journal of Clinical Medicine.2023; 12(18): 6034.     CrossRef
  • Estrogen-Driven Growth of Focal Nodular Hyperplasia: Truth or Myth?
    Ashraf A. Ashhab, Ahmad Abu-Sulb, Ju Dong Yang, Mazen Noureddin, Vinay Sundaram, Alexander Kuo, Walid S. Ayoub
    ACG Case Reports Journal.2021; 8(1): e00531.     CrossRef
  • Management of focal nodular hyperplasia of the liver: Experience of 50 pediatric patients in a tertiary center
    Angelo Zarfati, Greg Chambers, Luca Pio, Florent Guerin, Virginie Fouquet, Stéphanie Franchi-Abella, Sophie Branchereau
    Journal of Pediatric Surgery.2020; 55(9): 1885.     CrossRef
  • Uncommon evolutions and complications of common benign liver lesions
    Federica Vernuccio, Maxime Ronot, Marco Dioguardi Burgio, Jérôme Lebigot, Wassim Allaham, Christophe Aubé, Giuseppe Brancatelli, Valérie Vilgrain
    Abdominal Radiology.2018; 43(8): 2075.     CrossRef
  • 15,874 View
  • 74 Download
  • 9 Web of Science
  • Crossref

Review

Hepatic neoplasm

The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase
Woo Kyoung Jeong, Young Kon Kim, Kyoung Doo Song, Dongil Choi, Hyo Keun Lim
Clin Mol Hepatol 2013;19(4):360-366.
Published online December 28, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.4.360

Hepatocyte specific contrast agents including gadoxetic acid and gadobenate dimeglumine are very useful to diagnose various benign and malignant focal hepatic lesions and even helpful to estimate hepatic functional reservoir. The far delayed phase image referred to as the hepatobiliary phase makes the sensitivity of detection for malignant focal hepatic lesions increased, but specificity of malignant diseases, including hepatocellular carcinoma, metastasis and cholangiocarcinoma, characterization remained to be undetermined.

Citations

Citations to this article as recorded by  Crossref logo
  • Longitudinal T1ρ quantification in chronic hepatitis B: from fibrosis staging to pegylated interferon-α therapeutic response tracking
    Xin-Gui Peng, Yufei Zhao, Zhi Qin, Yang Jiang, Jingyue Dai, Ying Cui
    European Journal of Radiology.2025; 190: 112203.     CrossRef
  • MRI findings of confluent hepatic fibrosis caused by different etiologies
    Dan Yu, Xiao-Hua Li, Xue-Lin He, Xi-Bin Jia, Zhen-Chang Wang, Zheng-Han Yang, A-Hong Ren
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Case Report: Concurrent two adenomatoid tumors of liver
    Lei Bi
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Bildgebung von neuroendokrinen Tumoren des Gastrointestinaltrakts
    R. Ebner, J. Rübenthaler, J. Ricke, G. T. Sheikh, L. M. Unterrainer, C. J. Auernhammer, C. Spitzweg, M. Brendel, C. Schmid-Tannwald, C. C. Cyran
    Die Radiologie.2024; 64(7): 553.     CrossRef
  • PET/MRI for evaluation of patients with pancreatic cancer
    Zoey N. Duncan, David Summerlin, Janelle T. West, Annie T. Packard, Desiree E. Morgan, Samuel J. Galgano
    Abdominal Radiology.2023; 48(12): 3601.     CrossRef
  • Application of Pharmacokinetic Modeling to Characterize Hepatobiliary Disposition of Imaging Agents and Alterations due to Liver Injury in Isolated Perfused Rat Livers
    Angela Jeong, Catherine M. Pastor, Kim L. R. Brouwer
    Pharmaceutical Research.2023; 40(11): 2513.     CrossRef
  • Hepatobiliary phases in magnetic resonance imaging using liver-specific contrast for focal lesions in clinical practice
    Daniel Alvarenga Fernandes, Eduardo Andreazza Dal Lago, Felipe Aguera Oliver, Bruna Melo Coelho Loureiro, Daniel Lahan Martins, Thiago José Penachim, Ricardo Hoelz de Oliveira Barros, José de Arimatéia Batista Araújo Filho, Larissa Bastos Eloy da Costa, Á
    World Journal of Hepatology.2022; 14(7): 1459.     CrossRef
  • Tumor volume measured using MR volumetry as a predictor of prognosis after surgical resection of single hepatocellular carcinoma
    Sun Kyung Jeon, Dong Ho Lee, Juil Park, Kyung-Suk Suh, Nam-Joon Yi, Suk Kyun Hong, Joon Koo Han
    European Journal of Radiology.2021; 144: 109962.     CrossRef
  • MRI-Based Upper Abdominal Organs-at-Risk Atlas for Radiation Oncology
    Jelena Lukovic, Lauren Henke, Cihan Gani, Tae K. Kim, Teodor Stanescu, Ali Hosni, Patricia Lindsay, Beth Erickson, Richard Khor, Cynthia Eccles, Cheng Boon, Mila Donker, Raj Jagavkar, Marlies E. Nowee, William A. Hall, Parag Parikh, Laura A. Dawson
    International Journal of Radiation Oncology*Biology*Physics.2020; 106(4): 743.     CrossRef
  • Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the Liver
    Julia Greiser, Wolfgang Weigand, Martin Freesmeyer
    Pharmaceuticals.2019; 12(3): 137.     CrossRef
  • Focal Nodular Hyperplasia of the Liver: Contrast‐Enhanced Ultrasonographic Features With Sonazoid
    Jongmee Lee, Woo Kyoung Jeong, Hyo K. Lim, Ah Young Kim
    Journal of Ultrasound in Medicine.2018; 37(6): 1473.     CrossRef
  • Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma
    Ah Yeong Kim, Dong Hyun Sinn, Woo Kyoung Jeong, Young Kon Kim, Tae Wook Kang, Sang Yun Ha, Chul Keun Park, Gyu Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Min-Ji Kim, Insuk Sohn, Sin-Ho Jung, Seung Woon Paik, Won Jae Lee
    Journal of Hepatology.2018; 68(6): 1144.     CrossRef
  • Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury
    Tobias Getzin, Faikah Gueler, Björn Hartleben, Marcel Gutberlet, Anja Thorenz, Rongjun Chen, Martin Meier, Jan Hinrich Bräsen, Thorsten Derlin, Dagmar Hartung, Hannah A. S. Lang, Hermann Haller, Frank Wacker, Song Rong, Katja Hueper
    European Radiology.2018; 28(10): 4455.     CrossRef
  • Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid‐enhanced MRI: Comparison with multiphasic multidetector computed tomography
    Ijin Joo, Jeong Min Lee, Dong Ho Lee, Su Joa Ahn, Eun Sun Lee, Joon Koo Han
    Journal of Magnetic Resonance Imaging.2017; 45(3): 731.     CrossRef
  • Effect of Gadoxetic Acid on Quantification of Hepatic Steatosis Using Magnetic Resonance Spectroscopy: A Prospective Study
    Ju Won Kim, Sung Mo Kim, Sook Hee Heo, Jin Woong Kim, Sang Soo Shin, Yong Yeon Jeong, Gwang Woo Jeong, Heoung Keun Kang
    Journal of the Korean Society of Radiology.2017; 76(4): 237.     CrossRef
  • Magnetic resonance findings of hepatic epithelioid hemangioendothelioma: emphasis on hepatobiliary phase using Gd-EOB-DTPA
    Jeong Hyun Lee, Woo Kyoung Jeong, Young Kon Kim, Won Jae Lee, Sang Yun Ha, Kyoung Won Kim, Jihun Kim
    Abdominal Radiology.2017; 42(9): 2261.     CrossRef
  • Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology

    Korean Journal of Radiology.2017; 18(3): 427.     CrossRef
  • Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis
    Seung Kak Shin, Yun Soo Kim, Seung Joon Choi, Young Sup Shim, Dong Hae Jung, Oh Sang Kwon, Duck Joo Choi, Ju Hyun Kim
    Medicine.2017; 96(29): e7278.     CrossRef
  • Quantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: differences between hepatocellular carcinoma, hepatic focal nodular hyperplasia and cavernous hemangioma
    Zhenpeng Peng, Chang Li, Tao Chan, Huasong Cai, Yanji Luo, Zhi Dong, Zi-Ping Li, Shi-Ting Feng
    Oncotarget.2017; 8(39): 65435.     CrossRef
  • ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents
    E. Neri, M. A. Bali, A. Ba-Ssalamah, P. Boraschi, G. Brancatelli, F. Caseiro Alves, L. Grazioli, T. Helmberger, J. M. Lee, R. Manfredi, L. Martì-Bonmatì, C. Matos, E. M. Merkle, B. Op De Beeck, W. Schima, S. Skehan, V. Vilgrain, C. Zech, C. Bartolozzi
    European Radiology.2016; 26(4): 921.     CrossRef
  • Hepatic enhancement of Gd‐EOB‐DTPA‐enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis
    Sunyoung Lee, Dongil Choi, Woo Kyoung Jeong
    Journal of Magnetic Resonance Imaging.2016; 44(5): 1339.     CrossRef
  • Image Findings of Sarcomatous Intrahepatic Cholangiocarcinoma Focused on Gd-EOB-DTPA Enhanced MRI: A Case Report
    Ki Beom Kim, Seong Hoon Kim
    Investigative Magnetic Resonance Imaging.2015; 19(1): 47.     CrossRef
  • CT of Hepatic Sarcoidosis: Small Nodular Lesions Simulating Metastatic Disease
    Duygu Herek
    Polish Journal of Radiology.2015; 80: 178.     CrossRef
  • Diagnosis and treatment of benign liver nodules: Brazilian Society of Hepatology (SBH) recommendations
    Edna Strauss, Adalgisa de Souza Paiva Ferreira, Alex Vianey Callado França, Andre Castro Lyra, Fabio Marinho do Rego Barros, Ivonete Silva, José Huygens Parente Garcia, Edison Roberto Parise
    Arquivos de Gastroenterologia.2015; 52(suppl 1): 47.     CrossRef
  • Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI
    Stefano Palmucci
    World Journal of Hepatology.2014; 6(7): 477.     CrossRef
  • 14,194 View
  • 146 Download
  • Crossref

Liver Imagings

Focal nodular hyperplasia: with a focus on contrast enhanced ultrasound
Ho Suk Kang, Byung Kook Kim, Chan Sup Shim
Korean J Hepatol 2010;16(4):414-417.
Published online December 31, 2010
DOI: https://doi.org/10.3350/kjhep.2010.16.4.414

Citations

Citations to this article as recorded by  Crossref logo
  • Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out?
    Christos Tsalikidis, Athanasia Mitsala, George Pappas-Gogos, Konstantinos Romanidis, Alexandra K. Tsaroucha, Michail Pitiakoudis
    Journal of Clinical Medicine.2023; 12(18): 6034.     CrossRef
  • Paediatric focal nodular hyperplasia: A case study of typical contrast-enhanced ultrasound findings with quantitative analysis and correlated with magnetic resonance imaging
    Andreas Panayiotou, Vasileios Rafailidis, Annamaria Deganello, Maria Sellars, Paul S Sidhu
    Ultrasound.2021; 29(2): 128.     CrossRef
  • LI-RADS ancillary features on contrast-enhanced ultrasonography
    Christoph F. Dietrich, Yi Dong, Yuko Kono, Cosmin Caraiani, Claude B. Sirlin, Xin-Wu Cui, An Tang
    Ultrasonography.2020; 39(3): 221.     CrossRef
  • 11,839 View
  • 60 Download
  • Crossref
Focal nodular hyperplasia-Like nodule
Won Jae Lee
Korean J Hepatol 2008;14(4):537-540.
Published online December 31, 2008
DOI: https://doi.org/10.3350/kjhep.2008.14.4.537

Citations

Citations to this article as recorded by  Crossref logo
  • A Case of Multiple Hypervascular Hyperplastic Liver Nodules in a Patient with No History of Alcohol Abuse or Chronic Liver Diseases
    Byoung Joo Do, In Young Park, So Yon Rhee, Jin Kyung Song, Myoung Kuk Jang, Seong Jin Cho, Eun Sook Nam, Eun Joo Yun
    The Korean Journal of Gastroenterology.2015; 65(5): 321.     CrossRef
  • 5,492 View
  • 27 Download
  • Crossref

Liver Pathology

Focal nodular hyperplasia-Like nodule in Liver cirrhosis
Haeryoung Kim, M.D., Ph.D., Young Nyun Park, M.D., Ph.D.1
Korean J Hepatol 2008;14(2):226-230.
Published online June 20, 2008
DOI: https://doi.org/10.3350/kjhep.2008.14.2.226

Citations

Citations to this article as recorded by  Crossref logo
  • Contrast-enhanced Ultrasound—State of the Art in North America
    Richard G. Barr, Stephanie R. Wilson, Andrej Lyshchik, Beth McCarville, Kassa Darge, Edward Grant, Michelle Robbin, Juergen Karl Wilmann, Wui K. Chong, Arthur Fleischer, Harriet J. Paltiel
    Ultrasound Quarterly.2020; 36(4S): S1.     CrossRef
  • 5,231 View
  • 44 Download
  • Crossref

Case Reports

A Case of Focal Nodular Hyperplasia of the Liver
heol Su Lim , Su Tek Lee , Dae Ghon Kim , Deuk Soo Ahn , Hee Chul Yu , Baik Hwan Cho
Korean J Hepatol 1997;3(4):337-343.
Focal nodular hyperplasia (FNH) is a rare, benign hepatic tumor which was usually discovered incidentally by imaging procedure performed for some other reasons. FNH is typically asymptomatic and, it seldom bleeds. There is no evidence to support any relation with primary liver cancer. Accordingly, the preferred management is conservative, and excision is reserved for large symptomatic and complicated lesion, or when the diagnosis remains uncertain. Although many cases of FNH has been described to date in the other countries, only four cases of FNH has been reported in Korean literature. In the present report we describe a 7 cm sized asymptomatic lesion of FNH in a 23-year-old woman, that was disclosed by various kinds of imaging procedure. The left lateral segmentectomy was performed. The mass was firm and showed areas of localized growth of mature hepatocytes and septal fibrosis accompanied with marginal ductal proliferation, consistent with FNH. It also displayed an incomplete stellate architectual configration consisted of a central fibrous scar. (Korean J Hepatol 1997;7:337 343)
  • 3,495 View
  • 13 Download
A Case of Hepatocellular Carcinoma Mimicking Focal Nodular Hyperplasia
Young Eun Joo, Young Ho Seo, Wan Sik Lee, Nam Jin Kim, Hyun Taek Ahn, Kang Seok Seo, Hyun Soo Kim, Jong Sun Rew, Sang Woo Juhng and Sei Jong Kim
Korean J Hepatol 1998;4(4):393-398.
Distinction of hepatocellular carcinoma from benign entities such as focal nodular hyperplasia is important because failure of prompt diagnosis could result in a missed opportunity for curative resection. The differential deagnosis, especially among focal nodular hyperplasia and adenoma and even hepatocellualr carcinoma, may ve difficult; and when using inly a single imaging method, the diagnosis is often equivocal. Therefore, a combination of imaging modalities is preferred. For focal nodular hyperplasia, the combination of computerized tomography (CT ), magnetic resonance imaging (MRI), and radionuclide scintigraphy showed a high sensitivity and specificity. But , histologic examination is required for the differential diagnos is of hepatic mass . We report a case of hepat ocellular carcinoma without clinical evidence of malignancy or serum elevat ion of tumor marker , that mimicked the CT , MRI, and radionuclide scint igraphic appearance of focal nodular hyperplasia. (Korean J Hepatol 1998;4:393 398)
  • 3,102 View
  • 16 Download
A Case of Focal Nodular Hyperplasia of the Liver
Un Hwi Park, M.D., Chang Min Cho, M.D., Young Doo Lee, M.D., Seung Yeup Lee, M.D., Won Young Tak, M.D., Young Oh Kweon, M.D., Sung Kook Kim, M.D., Yong Hwan Choi, M.D., Joon Mo Chung, M.D., Han Ik Bae, M.D.1 and Hyun Gyu Ryeom, M.D.2
Korean J Hepatol 2000;6(4):524-529.
Focal nodular hyperplasia (FNH) is a rare benign hepatic tumor occurring predominantly in women of childbearing age. Generally oral contraceptive is not associated with FNH but might accentuate the vascular abnormalities which may cause the lesion to enlarge and, very rarely, to rupture. FNH is typically asymptomatic and seldom bleeds. Often it is incidentally observed during imaging procedures performed for some other reasons. The histologic feature of FNH is characterized by areas of localized growth of mature hepatocytes and septal fibrosis. Surgical resection is seldom required because of the benign nature of the lesion and its lack of significant complication. We experienced a case of focal nodular hyperplasia without liver cirrhosis confirmed by surgical resection and histologic examination. in a 47-year-old man. (Korean J Hepatol 2000 ;6 :524 - 529)
  • 3,741 View
  • 15 Download

Original Article

Clinical Features of Surgically Resected Focal Nodular Hyperplasia of the Liver
Nam Cheol Hwang, M.D., Moon Seok Choi, M.D., Joon Hyoek Lee, M.D., Kwang Cheol Koh, M.D., Seung Woon Paik, M.D., Byung Chul Yoo, M.D., Jong Chul Rhee, M.D., Kwang-Woong Lee, M.D.*, Jae-Won Joh, M.D.* and Cheol Keun Park, M.D.
Korean J Hepatol 2004;10(2):135-141.
Background/Aims
Focal nodular hyperplasia (FNH) is a benign hepatic tumor with few serious complications and no malignant transformation. However, differential diagnosis between FNH and other liver tumors, especially hepatocellular carcinoma, is often difficult. Methods: Clinical features of surgically resected FNH were reviewed. From January, 1995 to February, 2003, 10 patients with surgically resected FNH were enrolled. Their age, sex, results of laboratory examination, imaging studies and pathologic findings were evaluated. Results: Median age was 37.5 years and sex ratio (male:female) was 1.5:1. In 5 cases, resection to exclude hepatic adenoma or HCC was performed. Four cases were diagnosed incidentally after surgery. Four patients had risk factors for HCC, such as hepatitis B virus infection, liver cirrhosis or both. The size of FNH was 3.2 2.2 cm. The most common site of the tumor was segment 6 (30.0%). Differential diagnosis with HCC was difficult in 5 of six cases in whom CT was performed. Although needle biopsies were performed preoperatively in 4 cases, it was difficult to distinguish FNH from hepatic adenoma or HCC. Conclusions: FNH was resected due to uncertainty of diagnosis, or incidentally during hepatectomy in patients with other liver disease. In the former, differential diagnosis with hepatic adenoma or HCC was a major problem despite extensive work-up including dynamic CT or biopsy. (Korean J Hepatol 2004;10:135-141)
  • 3,510 View
  • 15 Download

Liver Pathology

Focal Nodular Hyperplasia
So Young Jin
Korean J Hepatol 2005;11(3):293-297.
  • 3,680 View
  • 14 Download
Liver Imaging